Filing Details
- Accession Number:
- 0001209191-23-017292
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-08 17:45:43
- Reporting Period:
- 2023-03-06
- Accepted Time:
- 2023-03-08 17:45:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1786255 | Icosavax Inc. | ICVX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1874017 | Cassia Cearley | C/O Icosavax, Inc. 1930 Boren Ave., Suite 1000 Seattle WA 98101 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-06 | 5,000 | $7.75 | 151,847 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $7.62 and $7.83. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Billionaire Hedge Funds
